APE1/Ref-1-NPM1 proteins are linked to cancer aggressiveness, which supports the idea that interfering with the APE1/Ref-1-NPM1 interaction might enable improved sensitization of cancer cells to chemotherapy [55]. The gene discussed is APEX1; the disease is cancer.